DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Tutt A. Ellis P. Kilburn L. et al.
The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer.
http://www.abstracts2view.com/sabcs14/view.php?nu=SABCS13L_789
We do not assume any responsibility for the contents of the web pages of other providers.